Estrogen and DHT in the Prostate and ...the Scalp?
- Thread starter wookster
- Start date
OverMachoGrande
Senior Member
- Reaction score
- 43
OverMachoGrande
Senior Member
- Reaction score
- 43
Prostate. 2008 Apr 1;68(5):508-16.
The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK.
Zhang Z, Duan L, Du X, Ma H, Park I, Lee C, Zhang J, Shi J.
Department of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University, Tianjin, China.
BACKGROUND: Estrogen is involved in the development and progression of benign prostatic hyperplasia (BPH). It can stimulate proliferation of prostate stromal cells (PrSCs). However, the exact mechanism remains unclear. METHODS: We used the primary cultured human PrSCs and a prostate stromal cell line, WPMY-1, to examine the signaling pathways involved in estrogen-mediated proliferation of PrSCs. Cells were treated with 17beta-estradiol (E(2)) or BSA-E(2). Cell proliferation was assessed by the MTT assay and by cell counting. Western blot analysis was used to determine the status of activation of ERK1/2. RESULTS: Results indicated that both E(2) and BSA-E(2) stimulated proliferation of primary PrSCs and WPMY-1 cells. ERK was rapidly activated by E(2) and BSA-E(2). PD98059, which is a selective ERK inhibitor, significantly inhibited estrogen-induced cell proliferation. PrSCs expressed estrogen receptor alpha (ERalpha) and GPR30 but not ERbeta. Small hairpin RNA (shRNA) to ERalpha, but not to GPR30, blocked estrogen-mediated ERK activation and cell proliferation. CONCLUSIONS: The results indicated that estrogen could activate ERK pathway through the non-genomic ERalpha pathway, leading to proliferation of PrSCs. Prostate 68: 508-516, 2008. (c) 2008 Wiley-Liss, Inc.
The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK.
Zhang Z, Duan L, Du X, Ma H, Park I, Lee C, Zhang J, Shi J.
Department of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University, Tianjin, China.
BACKGROUND: Estrogen is involved in the development and progression of benign prostatic hyperplasia (BPH). It can stimulate proliferation of prostate stromal cells (PrSCs). However, the exact mechanism remains unclear. METHODS: We used the primary cultured human PrSCs and a prostate stromal cell line, WPMY-1, to examine the signaling pathways involved in estrogen-mediated proliferation of PrSCs. Cells were treated with 17beta-estradiol (E(2)) or BSA-E(2). Cell proliferation was assessed by the MTT assay and by cell counting. Western blot analysis was used to determine the status of activation of ERK1/2. RESULTS: Results indicated that both E(2) and BSA-E(2) stimulated proliferation of primary PrSCs and WPMY-1 cells. ERK was rapidly activated by E(2) and BSA-E(2). PD98059, which is a selective ERK inhibitor, significantly inhibited estrogen-induced cell proliferation. PrSCs expressed estrogen receptor alpha (ERalpha) and GPR30 but not ERbeta. Small hairpin RNA (shRNA) to ERalpha, but not to GPR30, blocked estrogen-mediated ERK activation and cell proliferation. CONCLUSIONS: The results indicated that estrogen could activate ERK pathway through the non-genomic ERalpha pathway, leading to proliferation of PrSCs. Prostate 68: 508-516, 2008. (c) 2008 Wiley-Liss, Inc.